SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-23-000064
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:13
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q frtx-20230630.htm   iXBRL 10-Q 828289
2 EX-3.2 a2023063010qex32.htm EX-3.2 106170
3 EX-31.1 a2023063010qex311.htm EX-31.1 10020
4 EX-31.2 a2023063010qex312.htm EX-31.2 9734
5 EX-32.1 a2023063010qex321.htm EX-32.1 9260
11 frtx-20230630_g1.jpg GRAPHIC 256028
  Complete submission text file 0000819050-23-000064.txt   4916722

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230630.xsd EX-101.SCH 34647
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT frtx-20230630_cal.xml EX-101.CAL 30264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT frtx-20230630_def.xml EX-101.DEF 137120
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230630_lab.xml EX-101.LAB 463337
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230630_pre.xml EX-101.PRE 278539
49 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230630_htm.xml XML 407384
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 231163980
SIC: 2836 Biological Products, (No Diagnostic Substances)